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A collection of 6,000 mutant yeast strains spanning nearly every gene offers new 
promise for identifying human genes involved in cellular responses to drugs, 
radiation and other treatments. 
 
 
Summary:  Recent developments in genetics with Baker’s Yeast, Saccharomyces 
cerevisiae, have provided quick new methods for identifying the genes that control 
cellular responses to treatment with a wide variety of agents, including chemicals and 
radiation.  This greatly increases the power of yeast as a model system for studying 
human cellular responses to these agents, and for identifying human genes important in 
DNA repair and cancer. 
 
The yeast Saccharomyces cerevisiae has long been used as a model organism for 
studying genetic and biochemical processes [1] (see also http://genome-
www.stanford.edu/Saccharomyces/literature.html for online reviews).  It is a unicellular 
microbial eukaryote combining a highly tractable molecular biology [2] with sexual 
reproduction and a very versatile genetic system.  These features make it the species of 
choice for many studies of mitosis, meiosis, DNA repair and other aspects of biology 
shared by more complex life forms.  Many yeast genes have homologues in human DNA, 
especially those involved in cell cycle control, meiosis and DNA repair [1].  Studying the 
yeast phenotypes of mutants in these genes leads to new knowledge of human genes 
important in cancer and other diseases. 
 
A complete mutant collection: 
All the DNA sequences comprising the genome of S. cerevisiae have been determined 
(see [3]). The genome sequence revealed that Baker’s Yeast contains about 6,200 genes, 
including those currently defined only as open reading frames (“ORFs”), i.e., stretches of 
DNA whose sequence implies coding for a protein not yet identified.  Each gene or ORF 
has been given a systematic name based on its physical position in the genome.  The 
Saccharomyces genome database (http://genome-www.stanford.edu/Saccharomyces/) 
allows online searches for information concerning mutant phenotypes, literature 
references and other information using this name or any gene names associated with it. 
Knowledge of these sequences has been put to good use.   An international consortium 
has constructed a set of nearly six thousand yeast strains each lacking the function of a 
different gene or ORF [4].  The collection contains haploid and diploid strains separately 
disrupted for nearly every non-essential ORF, and diploid strains in which one copy has 
been disrupted for most genes that are essential.  In each case, the gene has been replaced 
with an artificial DNA cassette integrated into the chromosome at the gene’s location.  
The cassette contains a functional gene, KANMX4, conferring resistance to the antibiotic 
geneticin (G418).  Wild-type yeast is sensitive to geneticin, hence cells containing the 
cassette (and thus lacking the original gene) can be identified by growth on medium 
containing the drug.  In addition, each cassette contains short sequences on either side of 
the KANMX gene that are separate and unique for each gene or ORF that is deleted.  
These two sequences are known as the UPTAG and DOWNTAG sequences, since they 
uniquely tag each deletion and effectively function as a “barcode”.  Finally, the UPTAG 
and DOWNTAG sequences are themselves separately flanked by short sequences that are 
common to all the cassettes, permitting the barcode DNA to be amplified by PCR using 
these common sequences as primers [5]. 
The availability of this set of strains each containing a separate mutation, and together 
spanning nearly every yeast gene, provides a powerful new scientific resource [2].  
Originally, in order to study the genetic control of a biological process, researchers 
treated wild-type yeast cells with mutagenic chemicals and identified survivors that 
demonstrated a chosen mutant phenotype.  This needed painstaking follow-up work to 
identify which genes were mutated, and there was seldom any guarantee that a collection 
of mutants would identify all the genes that controlled the phenotype being studied.   
Later, as reviewed by Ross-MacDonald [6], molecular  methods were devised to create  
sets of mutants on a larger scale, for example by insertion of a lacZ reporter gene at 
random sites throughout the genome [7].  In this approach, the yeast gene involved is 
disrupted by a reporter gene that causes yeast colonies to turn blue whenever its own 
promoter is activated.  Even these methods, however, have not generated  a complete and 
catalogued  set of yeast deletion mutants.  With the new mutant  set, it is easy to ask 
whether any given gene, when deleted, affects any chosen phenotype, rather than having 
to make new mutants each time and then work out which genes are affected.  It is worth 
noting, however, that point mutations  in  some genes may confer phenotypes that are not 
seen in deletion mutants, and viable point-mutants may be useful for studying genes 
whose deletion alleles confer lethality.  Hence, a role remains for new mutant  isolation, 
despite the significance of the deletion  set. 
Pooled mutants and microarrays: 
The area of DNA repair is a good example of the value of the deletions.  Two groups 
have recently used the set of strains to identify new radiation-sensitive mutants in genes 
not previously known to affect this phenotype.  First, Birrell et al. [8] used molecular 
methods to screen for ultraviolet radiation (UV) sensitivity simultaneously in 4,627 gene-
deleted diploid strains combined into a pool.  These authors used UV to treat cultures of 
yeast containing all the strains mixed together.  After irradiation, cells were allowed an 
18 hour growth period to amplify the survivors and dilute out cells that were killed or 
severely growth-impaired by the treatment.  DNA was then extracted from the cell 
population and all the barcode sequences were co-amplified by PCR, using the common 
flanking regions as primers.  The objective was to amplify the barcode DNA while 
preserving the ratios in which each unique barcode was represented in the population.  
Finally, the amplified DNA was hybridized to high-density oligonucleotide microarray 
grids (DNA TAG3, Affymetrix, Santa Clara, CA.) containing sets of four DNA strands 
for each mutant in separate positions, each strand being complementary to one of the 
UPTAG or DOWNTAG barcode strands [5].  The authors reasoned that the relative 
intensity of hybridization signal at each grid position should reflect the proportion of the 
total cassette DNA contributed by the mutant whose unique barcode sequences were 
hybridized there.   This in turn should reflect the relative cellular abundance of that 
mutant in the pool at the time of DNA extraction.  Mutants that were killed more than 
average by the treatment should be under-represented, giving below-average signal in the 
positions containing their complementary barcode strands.   
The authors averaged the signal intensity from the four barcode strands for each mutant 
and then determined each mutant’s ratio of signal intensity with UV to that without UV.  
In most cases, this ratio did not vary greatly from gene to gene, but for some mutants, a 
ratio markedly below the average was seen.  This implied a lower comparative cell 
survival for these mutants after UV treatment, leading to an under-representation of their 
DNA.  In essence, the method represents a molecular way of doing UV survival assays 
on 4,627 mutants simultaneously. 
The UV treatment results verified the methodology, since most genes previously known 
to be important in controlling UV-sensitivity  (reviewed in [9]) were re-identified by the 
authors’ screen.  Some potential new UV-sensitive mutants were also identified, and in 
these cases UV survival assays involving colony formation were done to verify the initial 
observations.  It is important to confirm sensitivity of new mutants in this way at several 
UV doses, and, in addition,  to confirm that the sensitivity of the strain is conferred by the 
known deletion it contains.  The survival assays showed that most, though not all, of the 
new strains initially identified by the hybridization signal intensity method were sensitive 
to UV killing.  Birrell et al. [8] then transformed each new mutant with a wild-type copy 
of the gene, and observed that this step corrected the defect in the newly identified 
mutants.   Hence the molecular method had identified some real new mutants and some 
false positives. 
Another test for false positives involves crossing haploid strains containing the new 
mutation with wild-type, and determining if the studied phenotype is observed in only 
those progeny that inherit the deleted gene.  If so, this confirms that the deletion  is 
responsible for the phenotype.  These crosses are also needed before more detailed study 
of the new mutants is undertaken, since independent changes including secondary 
mutations, aneuploidy, or spontaneous diploidisation can occur during yeast 
transformation.  These may modify the mutants strain’s phenotype even when this is 
conferred by the deletion itself.  
The UV-sensitivity study was largely done to demonstrate the effectiveness of the 
method, since much is already known about UV-repair in Saccharomyces.  The real 
promise of the genome-wide mutant collection and the screening method of Birrell et al. 
[8] lies in its application to other phenotypes.  New pharmaceutical agents or toxic 
chemicals can be studied in the same way, and the genetic pathways determining their 
utilisation, breakdown, or responses to their effects may be identified more completely 
and with less work thanks to this approach. 
 
More specific mutant screens: 
The microarray approach was also used successfully by Ooi et al. [10] in a more specific 
assay that screened for mutants blocked in non-homologous end joining repair (NHEJ) 
[11].  This pathway is required in yeast for rejoining plasmids that are cut at sites with no 
homology to the yeast genome. These cannot be repaired by recombination, and are 
ineffective at transforming yeast unless they can be re-circularised by NHEJ.  The authors 
used a marker on the plasmid to select for transformants in the whole pool of mutants and 
then determined the relative representation of each transformed mutant both with intact 
and with cut plasmid.  Mutants relatively under-represented in the transformants from the 
cut plasmid compared to the intact one were largely those defective in NHEJ.  A 
significant new gene, NEJ1, was identified and its phenotype was confirmed by other 
methods.   
 
Directly testing the mutants: 
In another approach, Bennett et al. [12] used more conventional means to study radiation-
sensitivity in a subset of the new strain collection containing 3,670 homozygous diploid 
yeast deletion mutants.   They individually spot-tested each mutant for sensitivity to a 
single dose of gamma rays.  They made a preliminary identification of 107 new mutants 
showing gamma-ray sensitivity.  Most of these mutants have not yet been confirmed as 
sensitive by rigorous survival assays.  In addition, Bennett et al. did not confirm that the 
sensitivity of each presumptive mutant was conferred by the deleted gene, and in some 
cases their own data imply that it is not.  They spot-tested  the two haploid parents of 29 
of the presumptive new mutant diploids.  In 8 of these, at least one parent showed no 
gamma-ray sensitivity, despite containing the disrupted gene, and in another 3 mutants 
the sensitivity of one parent was much less than that of the other parent.  The haploid 
parents of the remaining 78 mutants were not tested.  Nevertheless, their study identified 
strains that can now be further assessed by well-established methods.  A broadly similar 
approach was used earlier by Chan et al. [13] to screen  for rapamycin-resistant mutants 
in a subset of the haploid deletion strains. 
 
Other ways to exploit the mutants: 
In a different use of the mutants, Tong et al. [14] devised a genetic strategy for quick 
identification of deletion mutants that are inviable when present in a double-mutant 
combination with any known mutant of interest.  Such inviable doubles, known as 
synthetic lethals, can identify potential new genes that are involved in the same area of 
metabolism that is affected by the known gene.  Using these newly found mutants 
themselves as the starting point for further synthetic lethal screens allows networks of 
synthetic lethality to be constructed in step-wise fashion, connecting ever-wider areas of 
metabolism [14].  This should eventually give enormous new information about pathways 
and about the third or so of yeast genes whose function still remains unknown.   
 
Looking ahead: 
The syergism between genome-wide molecular approaches and a mutant collection 
spanning an entire eukaryotic genome promises rapid progress towards a more global 
understanding of yeast gene functions in the near future.  Many human genes code for 
specialised functions not present in yeast.  However, the high homology between yeast 
and mammals for basic cell processes holds great promise for understanding human cell 
biology and disease genes as well as for better drug design [15].  
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